Published in J Cell Biol on November 01, 1995
Viral membrane fusion. Nat Struct Mol Biol (2008) 8.54
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26
The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol (1998) 4.07
Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol (1996) 3.77
Stalk model of membrane fusion: solution of energy crisis. Biophys J (2002) 3.51
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23
Close is not enough: SNARE-dependent membrane fusion requires an active mechanism that transduces force to membrane anchors. J Cell Biol (2000) 2.91
Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J Cell Biol (1996) 2.79
An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids. J Cell Biol (1997) 2.73
The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membr Biol (2004) 2.59
Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol (1997) 2.47
A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell (1999) 2.34
Flickering fusion pores comparable with initial exocytotic pores occur in protein-free phospholipid bilayers. Proc Natl Acad Sci U S A (1997) 2.25
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. J Cell Biol (1996) 2.25
The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J Cell Biol (2000) 2.13
Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol Biol Cell (1999) 2.10
Lipid intermediates in membrane fusion: formation, structure, and decay of hemifusion diaphragm. Biophys J (2002) 2.00
The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1998) 1.99
The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms. Biophys J (1997) 1.95
A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys J (1998) 1.90
The initial fusion pore induced by baculovirus GP64 is large and forms quickly. J Cell Biol (1996) 1.84
SNAREs can promote complete fusion and hemifusion as alternative outcomes. J Cell Biol (2005) 1.78
Lipid-anchored SNAREs lacking transmembrane regions fully support membrane fusion during neurotransmitter release. Neuron (2013) 1.78
Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proc Natl Acad Sci U S A (2005) 1.71
A new mechanism of model membrane fusion determined from Monte Carlo simulation. Biophys J (2003) 1.65
The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell (2000) 1.59
Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation. J Virol (2000) 1.56
Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J Cell Biol (1998) 1.50
Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion. Mol Biol Cell (2000) 1.47
A host-guest system to study structure-function relationships of membrane fusion peptides. Proc Natl Acad Sci U S A (2000) 1.47
Capture and release of partially zipped trans-SNARE complexes on intact organelles. J Cell Biol (2009) 1.45
A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol Biol Cell (2000) 1.43
Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J Virol (1997) 1.43
IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog (2014) 1.42
The transmembrane domain and cytoplasmic tail of herpes simplex virus type 1 glycoprotein H play a role in membrane fusion. J Virol (2002) 1.39
Membrane fusion mediated by coiled coils: a hypothesis. Biophys J (2000) 1.38
Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog (2007) 1.37
Effects of spontaneous bilayer curvature on influenza virus-mediated fusion pores. J Gen Physiol (1998) 1.36
Rabies virus-induced membrane fusion pathway. J Cell Biol (2000) 1.32
A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol (2004) 1.30
Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J Virol (1997) 1.29
Stalk phase formation: effects of dehydration and saddle splay modulus. Biophys J (2004) 1.28
Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J Virol (2006) 1.25
Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state. J Virol (2004) 1.24
Assays of vacuole fusion resolve the stages of docking, lipid mixing, and content mixing. Proc Natl Acad Sci U S A (2007) 1.24
Tension of membranes expressing the hemagglutinin of influenza virus inhibits fusion. Biophys J (1999) 1.24
Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore. J Virol (2000) 1.23
The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol Biol Cell (1999) 1.19
Transition from hemifusion to pore opening is rate limiting for vacuole membrane fusion. J Cell Biol (2005) 1.19
Voltage-dependent translocation of R18 and DiI across lipid bilayers leads to fluorescence changes. Biophys J (1996) 1.19
Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: a cryo-transmission electron microscopy study of liposome fusion. Biophys J (1997) 1.17
Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J Virol (2001) 1.17
Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin. Biophys J (1997) 1.16
Efficient infection mediated by viral receptors incorporated into retroviral particles. J Virol (1998) 1.14
Transmembrane orientation and possible role of the fusogenic peptide from parainfluenza virus 5 (PIV5) in promoting fusion. Proc Natl Acad Sci U S A (2011) 1.14
Lipid flow through fusion pores connecting membranes of different tensions. Biophys J (1999) 1.13
Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin. J Virol (1998) 1.13
Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion. PLoS Pathog (2011) 1.08
Rapid membrane fusion of individual virus particles with supported lipid bilayers. Biophys J (2007) 1.08
Transorganellar complementation redefines the biochemical continuity of endoplasmic reticulum and chloroplasts. Proc Natl Acad Sci U S A (2013) 1.03
Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion. J Virol (2003) 1.03
Cholesterol promotes hemifusion and pore widening in membrane fusion induced by influenza hemagglutinin. J Gen Physiol (2008) 1.01
Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin. J Virol (1998) 1.00
Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation. Biophys J (2001) 0.99
Fusion-pore expansion during syncytium formation is restricted by an actin network. J Cell Sci (2008) 0.99
Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J Virol (2001) 0.98
Effects of membrane potential and sphingolipid structures on fusion of Semliki Forest virus. J Virol (2002) 0.97
Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation. J Virol (2004) 0.95
Reovirus FAST protein transmembrane domains function in a modular, primary sequence-independent manner to mediate cell-cell membrane fusion. J Virol (2009) 0.93
Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis. Biophys J (2000) 0.92
Interaction of synthetic HA2 influenza fusion peptide analog with model membranes. Biophys J (2001) 0.92
Short-chain alcohols promote an early stage of membrane hemifusion. Biophys J (1999) 0.91
The Autographa californica multicapsid nucleopolyhedrovirus GP64 protein: analysis of transmembrane domain length and sequence requirements. J Virol (2009) 0.91
The final conformation of the complete ectodomain of the HA2 subunit of influenza hemagglutinin can by itself drive low pH-dependent fusion. J Biol Chem (2011) 0.91
Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge. Biophys J (1999) 0.90
Direct visualization of large and protein-free hemifusion diaphragms. Biophys J (2010) 0.90
Mutations in multiple domains activate paramyxovirus F protein-induced fusion. J Virol (2004) 0.88
Multiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles. Biophys J (2013) 0.86
Hemifusion and fusion of giant vesicles induced by reduction of inter-membrane distance. Eur Phys J E Soft Matter (2004) 0.85
The lipid composition and physical properties of the yeast vacuole affect the hemifusion-fusion transition. Traffic (2013) 0.85
Multifaceted sequence-dependent and -independent roles for reovirus FAST protein cytoplasmic tails in fusion pore formation and syncytiogenesis. J Virol (2009) 0.85
Novel entry pathway of bovine herpesvirus 1 and 5. J Virol (1998) 0.85
Alphavirus genome delivery occurs directly at the plasma membrane in a time- and temperature-dependent process. J Virol (2013) 0.84
Beyond anchoring: the expanding role of the hendra virus fusion protein transmembrane domain in protein folding, stability, and function. J Virol (2012) 0.83
Initial size and dynamics of viral fusion pores are a function of the fusion protein mediating membrane fusion. Biol Cell (2008) 0.82
Helix-destabilizing, beta-branched, and polar residues in the baboon reovirus p15 transmembrane domain influence the modularity of FAST proteins. J Virol (2011) 0.82
Hemagglutinin Spatial Distribution Shifts in Response to Cholesterol in the Influenza Viral Envelope. Biophys J (2015) 0.81
Lysophosphatidylcholine reversibly arrests pore expansion during syncytium formation mediated by diverse viral fusogens. J Virol (2014) 0.81
Negative potentials across biological membranes promote fusion by class II and class III viral proteins. Mol Biol Cell (2010) 0.80
Evolution of the hemifused intermediate on the pathway to membrane fusion. Biophys J (2012) 0.79
An aromatic side chain is required at residue 8 of SU for fusion of ecotropic murine leukemia virus. J Virol (2004) 0.78
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss. BMC Biotechnol (2014) 0.78
Stochastic simulation of hemagglutinin-mediated fusion pore formation. Biophys J (2001) 0.77
Pinpointing retrovirus entry sites in cells expressing alternatively spliced receptor isoforms by single virus imaging. Retrovirology (2014) 0.77
How Viruses Invade Cells. Biophys J (2016) 0.76
The transmembrane domain and acidic lipid flip-flop regulates voltage-dependent fusion mediated by class II and III viral proteins. PLoS One (2013) 0.76
Biochemical reconstitution of hemorrhagic-fever arenavirus envelope glycoprotein-mediated membrane fusion. PLoS One (2012) 0.76
Direct observation of intermediate states in model membrane fusion. Sci Rep (2016) 0.76
Intracellular aspects of the process of protein synthesis. Science (1975) 25.21
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. J Mol Biol (1967) 10.36
A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell (1993) 8.26
Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology (1983) 7.26
Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol (1993) 6.62
Membrane fusion. Science (1992) 5.91
Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell (1994) 5.65
Potocytosis: sequestration and transport of small molecules by caveolae. Science (1992) 4.94
Patch-clamp techniques for time-resolved capacitance measurements in single cells. Pflugers Arch (1988) 4.88
Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science (1994) 4.36
Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. J Biol Chem (1985) 4.32
Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys J (1993) 3.82
Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol (1987) 3.52
Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals. J Neurosci (1992) 3.45
Intermediates in influenza induced membrane fusion. EMBO J (1990) 3.24
Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers. Biochim Biophys Acta (1987) 2.91
Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J Cell Biol (1994) 2.87
Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature (1989) 2.83
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence. J Biol Chem (1989) 2.82
The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition. Biophys J (1995) 2.55
H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry (1985) 2.44
Exocytosis. Annu Rev Physiol (1990) 2.42
Membrane fusion during secretion. A hypothesis based on electron microscope observation of Phytophthora Palmivora zoospores during encystment. J Cell Biol (1977) 2.32
Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J Cell Biol (1993) 2.24
Proton pumps populate the contractile vacuoles of Dictyostelium amoebae. J Cell Biol (1993) 2.18
The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J Biol Chem (1991) 2.07
Stalk mechanism of vesicle fusion. Intermixing of aqueous contents. Eur Biophys J (1989) 2.03
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J (1994) 2.01
The exocytotic fusion pore modeled as a lipidic pore. Biophys J (1992) 1.99
Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide". J Biol Chem (1989) 1.96
GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J Cell Biol (1993) 1.78
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J (1995) 1.74
Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity. J Virol (1992) 1.74
Kinetics of ultrastructural changes during electrically induced fusion of human erythrocytes. J Membr Biol (1986) 1.66
Membrane events involved in myoblast fusion. J Cell Biol (1979) 1.59
Role of hydrophobic forces in bilayer adhesion and fusion. Biochemistry (1992) 1.58
Permeability properties of phospholipid membranes: effect of cholesterol and temperature. Biochim Biophys Acta (1972) 1.56
Evidence for H(+)-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane. J Biol Chem (1994) 1.44
Characteristics of self-quenching of the fluorescence of lipid-conjugated rhodamine in membranes. J Biol Chem (1990) 1.43
An architecture for the fusion site of influenza hemagglutinin. FEBS Lett (1990) 1.38
Tensions and free energies of formation of "solventless" lipid bilayers. Measurement of high contact angles. Biophys J (1983) 1.32
Delivery of macromolecules into cells expressing a viral membrane fusion protein. Methods Cell Biol (1989) 1.31
Influenza hemagglutinin-mediated fusion pores connecting cells to planar membranes: flickering to final expansion. J Gen Physiol (1993) 1.31
Membrane fusion without cytoplasmic fusion (hemi-fusion) in erythrocytes that are subjected to electrical breakdown. Biochim Biophys Acta (1991) 1.23
Influenza virus hemagglutinin-induced cell-planar bilayer fusion: quantitative dissection of fusion pore kinetics into stages. J Gen Physiol (1993) 1.16
How to make a glycoinositol phospholipid anchor. Trends Biochem Sci (1992) 1.10
Asymmetric membranes resulting from the fusion of two black lipid bilayers. Biochim Biophys Acta (1974) 1.06
Divalent cation induced fusion and lipid lateral segregation in phosphatidylcholine-phosphatidic acid vesicles. Biochemistry (1986) 1.05
An osmotic model for the fusion of biological membranes. FEBS Lett (1986) 1.03
Movements of fluorescent probes in the mechanism of cell fusion induced by poly(ethylene glycol). J Cell Sci (1987) 0.99
Protein conformational changes in virus-cell fusion. Methods Enzymol (1993) 0.99
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell (1996) 10.49
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell (1994) 5.65
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol (2005) 4.19
Water-borne outbreak of campylobacter gastroenteritis. Lancet (1983) 3.97
Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol (1996) 3.77
A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature (1992) 3.71
Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes. Biophys J (2001) 3.68
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67
Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A (1978) 3.42
Simultaneous electrical and optical measurements show that membrane fusion precedes secretory granule swelling during exocytosis of beige mouse mast cells. Proc Natl Acad Sci U S A (1987) 3.37
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell (1998) 3.25
Intermediates in influenza induced membrane fusion. EMBO J (1990) 3.24
Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J Bacteriol (1994) 3.12
Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science (2001) 3.11
A quantitative model for membrane fusion based on low-energy intermediates. Proc Natl Acad Sci U S A (2001) 3.01
Fusion of phospholipid vesicles with planar phospholipid bilayer membranes. II. Incorporation of a vesicular membrane marker into the planar membrane. J Gen Physiol (1980) 2.86
Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature (1989) 2.83
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence. J Biol Chem (1989) 2.82
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
COVER (cover of vaccination evaluated rapidly): description of the England and Wales scheme. Public Health (1989) 2.77
Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry (1990) 2.73
Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol (1997) 2.47
Osmotic swelling of phospholipid vesicles causes them to fuse with a planar phospholipid bilayer membrane. Science (1982) 2.43
ADAMs: focus on the protease domain. Curr Opin Cell Biol (1998) 2.42
A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell (1999) 2.34
Mouse egg integrin alpha 6 beta 1 functions as a sperm receptor. Cell (1995) 2.32
Identification of a prenylation site in delta virus large antigen. Science (1992) 2.29
Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J Cell Biol (1997) 2.21
The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J Virol (1994) 2.17
Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain. Lancet (1984) 2.16
The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J Cell Biol (2000) 2.13
Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J Virol (1995) 2.10
Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol Biol Cell (1999) 2.10
Hyperalgesic responses in methadone maintenance patients. Pain (2001) 2.09
A randomized clinical trial of anticaries therapies targeted according to risk assessment (caries management by risk assessment). Caries Res (2012) 2.08
ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol (1995) 2.00
Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract (2002) 2.00
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J Virol (1990) 2.00
Fusion of phospholipid vesicles with planar phospholipid bilayer membranes. I. Discharge of vesicular contents across the planar membrane. J Gen Physiol (1980) 1.97
Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J Virol (1990) 1.97
Tetanus in England and Wales, 1984-2000. Epidemiol Infect (2003) 1.93
Osmotic swelling of vesicles: its role in the fusion of vesicles with planar phospholipid bilayer membranes and its possible role in exocytosis. Annu Rev Physiol (1986) 1.93
Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J Virol (1990) 1.91
Proteolytic processing of a protein involved in sperm-egg fusion correlates with acquisition of fertilization competence. J Cell Biol (1990) 1.90
Structure-function of the channel-forming colicins. Annu Rev Biophys Biomol Struct (1995) 1.89
In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J Virol (1990) 1.79
trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol (1991) 1.79
GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J Cell Biol (1993) 1.78
UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiol Infect (2000) 1.77
ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol (1995) 1.73
Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect (2010) 1.72
Video fluorescence microscopy studies of phospholipid vesicle fusion with a planar phospholipid membrane. Nature of membrane-membrane interactions and detection of release of contents. J Gen Physiol (1987) 1.71
Parameters affecting the fusion of unilamellar phospholipid vesicles with planar bilayer membranes. J Cell Biol (1984) 1.71
Exocytotic fusion pores exhibit semi-stable states. J Membr Biol (1993) 1.62
Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. J Virol (1992) 1.59
The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell (2000) 1.59
Recombination signal sequences restrict chromosomal V(D)J recombination beyond the 12/23 rule. Nature (2000) 1.57
Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation. J Virol (2000) 1.56
Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth. J Virol (2004) 1.52
Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr Biol (2001) 1.51
Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry (1993) 1.51
Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc Natl Acad Sci U S A (1994) 1.48
The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications. Proc Natl Acad Sci U S A (1993) 1.45
Studies on the mechanism of action of channel-forming colicins using artificial membranes. J Membr Biol (1984) 1.45
Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia. J Med Genet (1986) 1.44
Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol (1994) 1.44
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J Virol (2003) 1.43
A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol Biol Cell (2000) 1.43
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol (1982) 1.43
ADAMs in fertilization and development. Dev Biol (1996) 1.42
The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev (2000) 1.42
Plasmapheresis in Raynaud's disease. Lancet (1978) 1.39
Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci U S A (1999) 1.39
Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein. J Virol (1998) 1.37
The fusion kinetics of influenza hemagglutinin expressing cells to planar bilayer membranes is affected by HA density and host cell surface. J Gen Physiol (1995) 1.36
Effects of spontaneous bilayer curvature on influenza virus-mediated fusion pores. J Gen Physiol (1998) 1.36
"Entropic traps" in the kinetics of phase separation in multicomponent membranes stabilize nanodomains. Biophys J (2006) 1.34
Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein. J Virol (2000) 1.33
Membrane mechanics can account for fusion pore dilation in stages. Biophys J (1995) 1.33
The central proline of an internal viral fusion peptide serves two important roles. J Virol (2000) 1.33
Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity. J Cell Biol (1998) 1.33
Separation of the osmotically driven fusion event from vesicle-planar membrane attachment in a model system for exocytosis. J Cell Biol (1984) 1.33
Transanal hemorrhoidal dearterialization is an alternative to operative hemorrhoidectomy. Am J Surg (2001) 1.32
The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores. Virology (1997) 1.31
Delivery of macromolecules into cells expressing a viral membrane fusion protein. Methods Cell Biol (1989) 1.31